<?xml version="1.0" encoding="iso-8859-1"?><?xml-stylesheet href="http://www.congoo.com/css/rss.css" type="text/css" media="screen"?><rss version="2.0"><channel><title>Biotech News - Congoo</title><link>http://www.congoo.com/feed/newschannelsfeed.aspx?chid=23&amp;catid=134</link><description>News Feed for - Biotech</description><item><title>Is Gene-Therapy Medical Treatment Ready for Prime Time?</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=96649086&amp;Channel_ID=23&amp;Category_ID=134</link><pubDate>2009-11-27T12:51:00</pubDate><description>At first it sounded like science fiction, curing genetic diseases by giving people new genes. Then it seemed like simple fiction: while theoretically possible, gene therapy appeared unlikely to become </description><source>Time</source></item><item><title>Incyte signs collaboration and licensing agreement with Novartis ...</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=96653999&amp;Channel_ID=23&amp;Category_ID=134</link><pubDate>2009-11-27T11:15:00</pubDate><description>Company: Novartis AG (NVS) Incyte, a US-based drug discovery and development company, has entered into a collaboration and licensing agreement with Swiss pharmaceutical group Novartis for two of its investigational </description><source>Zibb</source></item><item><title>Is Gene-Therapy Medical Treatment Ready for Prime Time?</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=96661044&amp;Channel_ID=23&amp;Category_ID=134</link><pubDate>2009-11-27T12:58:00</pubDate><description>At first it sounded like science fiction, curing genetic diseases by giving people new genes. Then it seemed like simple fiction: while theoretically possible, gene therapy appeared unlikely to become </description><source>Time</source></item><item><title>FSA to canvass pubic opinion on GM foods</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=96663395&amp;Channel_ID=23&amp;Category_ID=134</link><pubDate>2009-11-27T13:13:00</pubDate><description>THE Food Standards Agency (FSA) is launching a mass public consultation to engage consumers on the controversial debate over GM foods. At the request of Government the FSA has set up the GM dialogue steering </description><source>Farmers Guardian</source></item><item><title>Incyte enters collaboration &amp; license pact with Novartis for 2 haematology-oncology </title><link>http://www.congoo.com/news/addstorycomment.aspx?st=96661409&amp;Channel_ID=23&amp;Category_ID=134</link><pubDate>2009-11-27T12:55:00</pubDate><description>Incyte Corporation has entered into a collaboration and license agreement with Novartis for two of its investigational haematology-oncology therapies: INCB18424, an oral JAK1/JAK2 inhibitor that is in </description><source>PharmaBiz</source></item><item><title>Conference calls for strategy to guide biotech industry</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=96647570&amp;Channel_ID=23&amp;Category_ID=134</link><pubDate>2009-11-27T09:37:00</pubDate><description>MENAFN - Jordan Times - 27/11/2009 (MENAFN - Jordan Times) Experts have called for policies and strategies to guide the biotechnology industry and stem cell research in Jordan. At the conclusion of the </description><source>MENAFN</source></item><item><title>Postdoctoral Research in Functional Genomics</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=96641302&amp;Channel_ID=23&amp;Category_ID=134</link><pubDate>2009-11-27T08:03:00</pubDate><description>Homepage &gt; Job search &gt; Job description : Boston, MA Employer: Location: Boston, MA Posted: November 23, 2009 Expires: January 22, 2010 Jobs by tag(s): biostatistics ma Harvard Boston Requisition number: </description><source>Nature</source></item><item><title>Sinovac forms JV to expand human vaccine capabilities</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=96533632&amp;Channel_ID=23&amp;Category_ID=134</link><pubDate>2009-11-27T08:00:00</pubDate><description>Chinese vaccine major Sinovac Biotech has established a joint venture (JV), Sinovac (Dalian) Vaccine Technology Limited, to expand its human-use vaccine development and manufacturing capabilities. Sinovac </description><source>Bio Spectrum Asia</source></item><item><title>Human Genome Sciences submits Zalbin BLA to US FDA to treat chronic hepatitis C</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=96464204&amp;Channel_ID=23&amp;Category_ID=134</link><pubDate>2009-11-27T08:06:00</pubDate><description>Human Genome Sciences, Inc has submitted a Biologics License Application (BLA) to the US Food and Drug Administration (FDA) for Zalbin (albinterferon alfa-2b) for the treatment of chronic hepatitis C. </description><source>PharmaBiz</source></item><item><title>Bayer CropScience signs Agreement with GVK Biosciences on early-stage research projects</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=96378807&amp;Channel_ID=23&amp;Category_ID=134</link><pubDate>2009-11-27T06:40:00</pubDate><description>ayer CropScience and GVK Biosciences Private Limited (GVK BIO), Hyderabad, India, have entered into a research cooperation in the area of early discovery chemistry. The objective is to speed up the search </description><source>Chemie.de</source></item><item><title>Monsanto Fund Helping Keep Kids Safe by Sponsoring FS4JK</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=96558232&amp;Channel_ID=23&amp;Category_ID=134</link><pubDate>2009-11-27T05:46:00</pubDate><description>The Monsanto Fund, the philanthropic arm of Monsanto Company, recently made the safety of our youth a priority by sponsoring Farm Safety 4 Just Kids (FS4JK), Urbandale, Iowa, with a $14,000 grant. Farm </description><source>USAgNet</source></item><item><title>Swedish Biovitrum expands Kineret licence from Amgen</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=96639064&amp;Channel_ID=23&amp;Category_ID=134</link><pubDate>2009-11-27T11:32:00</pubDate><description>- Swedish biotech company Biovitrum (STO:BVT) said today that it agreed with US sector major Amgen Inc (NASDAQ:AMGN) to expand Biovitrum's licence to the rheumatoid arthritis drug Kineret to include certain </description><source>ADP News</source></item><item><title>Chugai Revises Corporate Advertisement for First Time in Four Years</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=96483170&amp;Channel_ID=23&amp;Category_ID=134</link><pubDate>2009-11-27T03:53:00</pubDate><description>Spreading the message of Chugai's corporate mission of offering innovative drugs for cancer, rheumatoid arthritis, renal anemia and hepatitis C November 25, 2009 (Tokyo) - Chugai Pharmaceutical Co., Ltd. </description><source>CHUGAI PHARMACEUTICAL</source></item><item><title>Why GMOs Are Bad</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=96618253&amp;Channel_ID=23&amp;Category_ID=134</link><pubDate>2009-11-27T02:22:00</pubDate><description>Science of the Organism &amp;amp; Sustainable Systems Invited lecture, The Alternative View, 13-15 November, Grand Thistle Hotel, Bristol, UK Monsanto has surreptitiously withdrawn its high lysine GM maize </description><source>Institute of Sciences in Society</source></item><item><title>BiomedReports: News and FDA Updates for GLG (NASDAQ:GLGL), Human Genome Sciences </title><link>http://www.congoo.com/news/addstorycomment.aspx?st=96602577&amp;Channel_ID=23&amp;Category_ID=134</link><pubDate>2009-11-27T02:41:00</pubDate><description>(M2 PRESSWIRE via COMTEX) -- BioMedReports. Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors </description><source>TMC Net</source></item><item><title>Kun Run Biotechnology, Inc. Announces Third Quarter 2009 Results</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=96654750&amp;Channel_ID=23&amp;Category_ID=134</link><pubDate>2009-11-27T11:48:00</pubDate><description>- (NewsRx.com) -- Kun Run Biotechnology, Inc. (the 'Company' or 'Kun Run') (BULLETIN BOARD: KURU) , a leading bio-pharmaceutical company in China that focuses on manufacturing and sales of peptides and </description><source>Poten &amp; Partners</source></item><item><title>Bayer CropScience to speed crop protection R&amp;D in agreement with GVK Biosciences</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=96647007&amp;Channel_ID=23&amp;Category_ID=134</link><pubDate>2009-11-27T09:29:00</pubDate><description>MONHEIM, Germany &amp; HYDERABAD, India -- Bayer CropScience and GVK Biosciences Private Limited, Hyderabad, India, have entered into a research cooperation in the area of early discovery chemistry. The objective </description><source>AgProfessional</source></item><item><title>Gyros, DI Biotech sign distribution agreement for the Korean market</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=96616782&amp;Channel_ID=23&amp;Category_ID=134</link><pubDate>2009-11-27T09:53:00</pubDate><description>Gyros, a top developer of automated micro-immunoassays for therapeutic protein development has signed a distribution agreement with DI Biotech, the leading supplier to the Korean life-science market. </description><source>Bio Spectrum Asia</source></item><item><title>Diabetes - Sanofi-Aventis Ensures Product Quality with Mettler Toledo Checkweighers</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=96483909&amp;Channel_ID=23&amp;Category_ID=134</link><pubDate>2009-11-27T08:32:00</pubDate><description>Learn more about a six-week, no-risk free trial of Fitness &amp;amp; Wellness Business Week We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00. Sanofi-Aventis </description><source>NewsRX</source></item><item><title>Turkey genome sequencing grant is awarded</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=96636853&amp;Channel_ID=23&amp;Category_ID=134</link><pubDate>2009-11-27T07:09:00</pubDate><description>Virginia Tech and the University of Minnesota have been awarded a 2-year, $908,280 grant by the USDA to complete sequencing the genome of the domesticated turkey, Meleagris gallopavo. The funding will </description><source>WorldPoultry.net</source></item><item><title>Nanoparticle oral drug delivery systems show promise for biotech firm</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=96633737&amp;Channel_ID=23&amp;Category_ID=134</link><pubDate>2009-11-27T06:33:00</pubDate><description>Drug company NOD Pharmaceuticals Inc.'s application to the US Patent and Trademark office for a patent for a nanoparticle drug carrying method has been allowed, the company says. Nanoparticle drug delivery </description><source>Nanotechnology News</source></item><item><title>Agilent Technologies Expands Ultra-High-Performance Liquid Chromatography Portfolio </title><link>http://www.congoo.com/news/addstorycomment.aspx?st=96627154&amp;Channel_ID=23&amp;Category_ID=134</link><pubDate>2009-11-27T06:32:00</pubDate><description>Santa Clara, California, USA - Agilent Technologies Inc. today introduced the 1290 Infinity LC Injector HTS/HTC sample injection system offering superior performance in speed, ultra-low carryover, and </description><source>Spectroscopy Now</source></item><item><title>Soil Association calls for compulsory labelling of food from GM crops in light of </title><link>http://www.congoo.com/news/addstorycomment.aspx?st=96628029&amp;Channel_ID=23&amp;Category_ID=134</link><pubDate>2009-11-27T05:27:00</pubDate><description>The Soil Association today wrote to the new Chair of the Food Standards Agency (FSA), Lord Rooker, asking him to support the compulsory labelling of any meat or dairy products from animals fed on GM animal </description><source>Soil Association</source></item><item><title>MOgene, LC Participates in Consortium That Sequenced Three Oil Palm Genomes</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=96627489&amp;Channel_ID=23&amp;Category_ID=134</link><pubDate>2009-11-27T05:23:00</pubDate><description>- (NewsRx.com) -- MOgene, a member of a consortium co-led by the Malaysian Palm Oil Board (MPOB) and Orion Genomics, announced the sequencing of three oil palm genomes, two of which originated in Africa </description><source>Poten &amp; Partners</source></item><item><title>Joule Reports Breakthrough in Renewable Diesel Production Joule Biotechnologies</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=96626369&amp;Channel_ID=23&amp;Category_ID=134</link><pubDate>2009-11-27T05:13:00</pubDate><description>Joule Biotechnologies, Inc. announced a major step forward in its development of renewable fuels, achieving direct microbial conversion of carbon dioxide (CO2) into hydrocarbons via engineered organisms, </description><source>Poten &amp; Partners</source></item></channel></rss>